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Abstract 
 
U.S. government subsidies under the HITECH Act of 
2009 have boosted hospitals’ IT investments, which are 
expected to improve the quality of care as well as the 
effectiveness of healthcare management. Given the rush 
to adopt health information technology (HIT) 
throughout the continuum of care across healthcare 
providers, this study tries to identify the spillover effects 
of HIT adoption on quality of care. Using 1,965 U.S. 
hospital data in 232 health referral regions (HRRs), we 
examine how a hospital’s and its neighboring hospitals’ 
HIT adoptions interact with each other and how they 
impact readmission rates. We find that a hospital’s 
readmission rate is reduced by both its own and 
neighbors’ HIT adoption. Such effects become greater 
along with the focal hospital’s own adoption. We further 
investigate how spillover effects vary with HRRs’ 
different market structures and hospitals’ meaningful-
use status. Our findings offer theoretical and 
managerial insights for both healthcare researchers 
and practitioners. 
 
1. Introduction 
 
Health information technology (HIT) has been 
expected to help healthcare providers better manage the 
timeliness and accuracy of patient care by supporting 
effective clinical decisions and information sharing 
among patients and their caregivers. Thanks to the 
Health Information Technology for Economic and 
Clinical Health (HITECH) Act of 2009, U.S. healthcare 
providers have been given financial incentives linked to 
HIT adoption. More than $35 billion in incentives has 
promoted HIT implementation, resulting in 96% of 
hospitals having a certified electronic health records 
program in 2017—a nine-fold increase since 2008 [22]. 
                                                 
1 A clinical decision support system (CDSS) uses knowledge bases 
for providing clinical information at the point of care to drive 
evidence-based treatment (e.g., clinical guidelines and reminders, 
During the last decade, this dramatically increased 
HIT adoption has promoted healthcare researchers 
justify the government initiatives to drive large private 
and public investments. However, most of the prior 
studies have focused on the hospital- or physician-level 
effects of HIT adoption on healthcare quality and costs 
[1, 2, 6]. 
However, unlike other industries, the healthcare 
sector often shares patient information as patients move 
across healthcare providers within a hospital referral 
region (HRR). Thus, a hospital’s HIT adoption does not 
only affect the adopter itself but also its neighboring 
hospitals. For instance, clinical and patient information 
from a clinical decision support system (CDSS) 1  is 
utilized by physicians in writing referral letters, which 
inform the medical decisions of referred hospitals in an 
HRR. Primary care physicians’ referrals to special 
services are often accompanied by information sharing 
through electronic data interchange (EDI), which 
expedites communication and collaboration among 
healthcare providers [17]. Therefore, the HIT adoptions 
of hospitals in an HRR seem to have spillover effects. 
In addition, the patterns of such referrals vary with 
an HRR’s market structure. If a single tertiary hospital 
dominates a local healthcare market, all primary and 
secondary care hospitals would not have any choice, 
whereas they would have multiple options otherwise. 
Thus, the spillover effect of HIT adoption on quality of 
care in HRRs having various market structures is an 
important empirical question. 
Although HIT adoption can result in the spillover 
effects in terms of better healthcare outcomes, some 
studies demonstrated that most of the benefits from HIT 
adoption are not caused by the simple implementation. 
The assimilation gap between the implementation and 
the actual usage of HIT [12] would explain the effects 
of HITs. Thus, we further consider the meaningful use 
of adopted HIT in our empirical models. 
drug allergy and drug-drug interaction alerts, and drug dosing support). 
It can integrate clinical workflows by supporting various managerial 
as well as medical decisions throughout the continuum of care. 
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With regard to the above discussions, our primary 
research questions are: (1) How does a hospital’s HIT 
adoption affect its quality of care? (2) Do the spillover 
effects of HIT adoption exist among hospitals in an 
HRR? (3) How do the spillover effects vary with 
different market structures? (4) How is the meaningful 
use of HITs related to the effects on healthcare quality? 
In order to answer the questions, the large-scale 
hospital panel datasets were obtained from multiple 
sources, including the Healthcare Information and 
Management Systems Society (HIMSS) Analytics 
database and the Centers for Medicare and Medicaid 
Services (CMS) website 2 . Our sample includes 
healthcare data involving 1,965 hospitals across 232 
HRRs from 2010 to 2015, such as adopted HITs and 
detailed healthcare quality. 
Our findings provide theoretical and practical 
implications by identifying the interdependence of HIT 
adoption among hospitals in an HRR. The contribution 
of the study lies in providing policy insights on effective 
healthcare policies across complex healthcare market 
structures. 
 
2. Research background 
 
The impact of HIT adoption has recently drawn 
attention from the community of Information Systems  
[1]. Several efforts have been devoted to examining its 
impacts on diverse dimensions, including productivity 
[7, 11, 13, 16, 20, 24], medical errors [2, 8, 15, 18], 
insurance premiums [19], and healthcare quality [4, 6, 
14, 23]. For example, Menon et al. [20] show that two 
healthcare information systems—clinical information 
systems and administrative information systems—have 
different impacts on patient days and medical labor 
productivity. Based on the results, they argue that 
aggregating HIT investment may not lead to a correct 
conclusion due to these different effects. Aron et al. [2] 
provide empirical evidence that automating the core 
error prevention functions between hospitals reduced 
their interpretative and procedural medical errors. 
Menon and Kohli [19] analyze hospital panel data in 
Washington State and show that past HIT expenditures, 
measured by depreciation expenses, are negatively 
associated with malpractice insurance premiums and are 
positively associated with healthcare quality. Bhargava 
and Mishra [7] focus on physician productivity after 
adopting electronic health records systems. They found 
that such an adoption could bring about immediate 
drops in physician productivity; however, these 
                                                 
2 The Centers for Medicare & Medicaid Services (CMS) is a federal 
agency as part of the U.S. Department of Health and Human Services. 
CMS serves Medicare and Medicaid beneficiaries and also oversees 
productivity drops can be recouped in the long run if the 
systems are a good fit with physicians’ task 
requirements. 
A few recent studies [3, 5, 21] have focused on the 
inter-organizational effects of HIT adoption, as well. 
Most notably, Atasoy et al. [3] find that adopting 
electronic health records reduces the cost of neighboring 
hospitals by creating significant regional spillover 
effects. Ayabakan et al. [5] show that medical test 
duplication can be reduced with inter-organizational 
information-sharing technologies. 
While prior literature has studied the effects of HIT 
from diverse perspectives, no study has considered the 
spillover effects of HIT on quality of care in HRRs 
having different market competitions. Thus, we aim to 
address these gaps in the literature by empirically 
examining how the interaction between the HIT 
adoptions of a focal hospital and its neighboring 
hospitals in an HRR influence quality of care. We focus 
not only on the main effect of HIT adoption but also on 
its spillover effects within the HRR. We also compare 
the spillover effects across HRRs with different market 
concentrations and discuss the role of meaningful use in 
generating the effects. 
Furthermore, we examine the technology 
interdependence between two HIT applications, 
particularly the role of EDI in generating the spillover 
effects of an adopted CDSS. Considering the spillover 
effects of HIT adoption in an HRR, EDI is one of the 
most important factors to facilitate the network effects 
of other HITs, while CDSS is a HIT application related 
to avoidance of errors and right clinical decisions 
resulting in enhanced health outcomes. Thus, to answer 
our research questions, we focus on investigating the 
spillover effects of a hospital’s EDI and CDSS adoption 
on its readmission rate, which is a widely accepted 
measure of healthcare quality. 
Our study provides evidence that the adoptions of 
both EDI and CDSS are positively associated with a 
subsequent reduction in readmission rates for heart 
failure across hospitals in the U.S. We also find that the 
average adoption rate of a hospital’s neighbors is 
significantly associated with a subsequent reduction in 
the hospital’s readmission rate. The effect is greater 
when both a hospital and its neighbors in an HRR have 
adopted the same technology. Lastly, the meaningful 
use of HITs, which is captured by the Stage 2 certificate, 
plays a role in explaining the HIT effects. 
The rest of the paper is organized as follows. We 
first describe our data and empirical model; then, we 
show the main analysis results. Subsequently, we 
many federal healthcare programs, including those that involve HIT 
such as the meaningful use incentive program for electronic health 
records (EHR). 
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conduct an analysis across subsamples with different 
market concentrations. Next, we examine whether EDI 
adoption supports the spillover effects of CDSS 
adoption in an HRR. We also conduct an HRR-level 
analysis to demonstrate the relationship between the 
average adoption rate of EDI and CDSS, as well as the 
hospital readmission rate of HRRs. Lastly, we examine 
how the meaningful use of HITs is related to the effects. 
We conclude our paper with theoretical contributions 
and future research directions. 
 
3. Empirical analysis 
 
3.1. Data description 
 
We obtained data from multiple sources. Hospitals’ 
IT infrastructure, HIT adoption, operating expenses and 
other organizational characteristics were collected from 
the HIMSS Analytics database. Readmission rates and 
meaningful-use status were collected from the CMS 
website. We matched the observations of the same 
hospital from different sources based on Medicare 
provider codes, hospital names, addresses and zip codes.  
Our interests reside in Medicare hospitals whose 
information has been publicly announced. Further, to 
examine possible spillover effects within an HRR, we 
chose HRRs that have at least three Medicare hospitals. 
The final longitudinal sample includes 232 HRRs and 
1,965 hospitals that have reported their annual status 
from 2010 to 2015. 
As noted earlier, in order to identify the spillover 
effects of HIT on quality of care, this study focuses on 
examining the effects of EDI and CDSS on subsequent 
readmission rates for heart failure patients. 
A hospital readmission is defined as “an unplanned 
admission to an acute care hospital within 30 days of 
discharge from the same or another acute care hospital” 
[10]. Readmission rates were collected from CMS as a 
three-year rolling average at the hospital level for heart 
failure. Readmission indicates a poor quality of 
healthcare service during the initial hospitalization, 
because a discharged patient’s health has worsened and 
financial costs increase. Since the U.S. government 
financially penalizes hospitals whose readmission rates 
are above a projected rate, hospitals have striven to 
lower their readmission rates. While a readmission rate 
has been accepted as a core quality measure, heart 
failure has been the leading diagnosis of hospital 
readmission, with a median risk-standardized 
readmission rate of 23%, from 2009 to 2012 [9]. 
Table 1 provides the definition and summary 
statistics of the main variables used in our analysis. 
Figure 1 illustrates the HRRs across states, which are 
used in our analysis. A larger and darker circle 
represents that more hospitals exist in the HRR. 
 
 
Figure 1. Hospitals in HRRs 
 
 
Table 1. Definition of key variables and descriptive statistics 
Variables Definition N Mean SD Min Max 
rhfscore 
Readmission rate of heart failure within 30 days 
following a discharge 
9,541 0.228 0.020 0.158 0.321 
EDI 
One year lagged adoption status of electronic 
data interchange (1=implemented, 0=otherwise)  
9,541 0.930 0.255 0 1 
CDSS 
One year lagged adoption ratio of the clinical 
decision support system 
9,541 0.691 0.342 0 1 
ln(nofcda) Number of computerized document applications 9,541 1.351 0.124 0 1.386 
ln(nofbeds) Number of beds 9,541 5.111 0.958 2.565 7.533 
ln(opexp) Operating expense (USD) 9,541 18.690 1.093 14.927 22.975 
ln(nofhrr) Number of hospitals in the referral regions 9,541 2.477 0.627 1.386 3.807 
HHI Herfindahl-Hirschman Index of referral regions 9,541 0.218 0.148 0.032 0.859 
Note: A clinical decision support system includes drug content and interactions, clinical guidelines and pathways for physicians, 
as well as clinical guidelines and pathways for nurses; computerized document applications include computerized practitioner order 
entries, clinical data repositories, electronic medical records, and electronic medication administration records.
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3.2. Empirical approach 
 
We employ a fixed effects model that controls for 
time-invariant hospital-level covariates. We examine 
how a hospital’s (and its neighboring hospitals’) HIT 
adoptions affect the hospital’s readmission rate (Eq. 1). 
We also consider the network effect of HIT adoption by 
incorporating the interaction term between the HIT 
adoption of the focal hospital and the adoption rate of its 
neighbors in an HRR into the main effect model (Eq. 2). 
Our model specifications are: 
 
𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1𝐻𝐼𝑇𝑖,𝑡−1 + 𝛽2𝐻𝐼𝑇𝑟−𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡 
               +𝜇𝑖 + 𝜀𝑖,𝑡          (Eq. 1) 
𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1𝐻𝐼𝑇𝑖,𝑡−1 + 𝛽2𝐻𝐼𝑇𝑟−𝑖,𝑡−1 
    +𝛽3𝐻𝐼𝑇𝑖,𝑡−1 × 𝐻𝐼𝑇𝑟−𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡 + 𝜇𝑖 + 𝜀𝑖,𝑡  (Eq. 2) 
 
where 𝑟ℎ𝑓𝑖,𝑡 is the readmission rate of the heart failure 
cases of hospital i at time t, 𝐻𝐼𝑇𝑖,𝑡−1 is the adoption state 
of the HIT (EDI or CDSS) of hospital i at time t-1, 
𝐻𝐼𝑇𝑟−𝑖,𝑡−1  is the average adoption rate of the other 
hospitals in the same HRR r, except for the focal 
hospital i at time t-1, 𝑋𝑖,𝑡  is a vector of the control 
variables, 𝜇𝑖  is the hospital-specific fixed effects, and 
𝜀𝑖,𝑡 is the disturbance term. 
Our control variables are time-varying hospital-level 
covariates, including the number of computerized 
document applications, number of beds, operating 
expenses, and an HRR’s market concentration. The 
number of computerized healthcare systems are 
included to control for effects due to the hospitals’ IT 
infrastructure. The number of beds and the operating 
expenses are included to control for the effect of 
organizational size. The number of hospitals and the 
Herfindahl-Hirschman Index (HHI) are included to 
control HRR’s market structure. Lastly, our fixed effects 
term controls for effects due to all time-invariant 
hospital-specific factors. 
 
 
3.3. Results 
 
Table 2 illustrates our results. Models (1) and (3) 
indicate that the coefficients of 𝐻𝐼𝑇𝑖,𝑡−1  are negative 
and significant for both EDI and CDSS (-0.006 and -
0.005 at p-value <0.01, respectively), demonstrating 
that the adoption status of those HITs is negatively 
associated with the subsequent readmission rates of 
heart failure patients. This result provides evidence of 
the positive effects of EDI and CDSS adoption on 
quality of care. 𝐻𝐼𝑇𝑟−𝑖,𝑡−1  also has a negative and 
significant coefficient for both EDI and CDSS (-0.058 
and -0.065 at p-value <0.01, respectively), implying that 
the average adoption rate of a hospital’s neighboring 
hospitals in an HRR is negatively associated with the 
subsequent readmission rate of the focal hospital. The 
results demonstrate the spillover effects of HITs within 
an HRR. 
In Models (2) and (4), we investigate the interaction 
effect between the adoption status of the focal hospital 
and the average adoption rate of the other hospitals. The 
coefficients of the interaction term of 𝐻𝐼𝑇𝑖,𝑡−1  and 
𝐻𝐼𝑇𝑟−𝑖,𝑡−1 are negative and significant for both EDI and 
CDSS (-0.016 at p-value <0.01 and -0.012 at p-value 
<0.05, respectively). These suggest that the spillover 
effects of HIT are stronger when both the focal hospital 
and its neighbors have adopted the same type of HIT. 
Among the control variables, the number of 
computerized document applications (nofcdai,t), the 
number of beds (nofbedi,t), the operating expense 
(opexpi,t), and the Herfindahl-Hirschman Index (HHIi,t) 
are negatively associated with the readmission rate. The 
number of hospitals in the referral region (nofhrri,t) is 
omitted from the analysis due to high multi-collinearity 
with other covariates (Mean VIF=14.22 in Model (6)). 
 
4. Additional analysis 
 
4.1. Subsample analysis 
 
With respect to our discussion in the introduction, a 
hospital’s choice for referrals requiring communication 
and information sharing between practitioners should be 
related to an HRR’s market structure. We employ the 
Herfindahl-Hirschman Index (HHI), which is a 
commonly accepted measure for market concentration 
in considering the spillover effects across HRRs having 
diverse market structures. According to the U.S. 
Department of Justice and the Federal Trade 
Commission, an index below 0.15 indicates that the 
market is unconcentrated, and an index between 0.15 
and 0.25 indicates that the market is moderately 
concentrated. An index above 0.25 indicates that the 
market is highly concentrated. We employ this cutoff to 
classify the HRRs each year. Our dataset includes 855, 
507, and 603 hospitals in the low, moderate, and high 
market concentration groups, respectively. 
We replicate our panel analysis for these three 
subsamples. Tables 3, 4, and 5 show the results from 
HHRs with an HHI of less than 0.15 (Panel A), between 
0.15 and 0.25 (Panel B), and more than 0.25 (Panel C), 
respectively. 
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Table 2. Estimation results 
Variables (1) (2) (3) (4) (5) (6) 
𝐸𝐷𝐼𝑖,𝑡−1 
-0.006*** 
(0.001) 
0.007 
(0.005) 
 
 0.002 
(0.005) 
0.001 
(0.005) 
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 
-0.058*** 
(0.002) 
-0.044*** 
(0.006) 
  -0.024*** 
(0.006) 
-0.028*** 
(0.006) 
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1  
-0.016*** 
(0.006) 
  -0.005 
(0.006) 
0.000 
(0.008) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1  
 -0.005*** 
(0.002) 
0.002 
(0.004) 
0.006* 
(0.004) 
0.003 
(0.003) 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1  
 -0.065*** 
(0.003) 
-0.056*** 
(0.004) 
-0.039*** 
(0.005) 
-0.030*** 
(0.006) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1  
 
 
-0.012** 
(0.005) 
-0.010* 
(0.005) 
-0.011** 
(0.005) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1     
-0.005* 
(0.003) 
 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1     
 -0.010* 
(0.005) 
ln(𝑛𝑜𝑓𝑐𝑑𝑎𝑖,𝑡) 
-0.022*** 
(0.002) 
-0.022*** 
(0.002) 
-0.020*** 
(0.002) 
-0.020*** 
(0.002) 
-0.018*** 
(0.002) 
-0.018*** 
(0.002) 
ln(𝑛𝑜𝑓𝑏𝑒𝑑𝑖,𝑡) 
-0.003 
(0.002) 
-0.003 
(0.002) 
-0.004** 
(0.002) 
-0.004** 
(0.002) 
-0.004* 
(0.002) 
-0.004* 
(0.002) 
ln(𝑜𝑝𝑒𝑥𝑝𝑖,𝑡) 
-0.004*** 
(0.001) 
-0.004*** 
(0.001) 
-0.004*** 
(0.001) 
-0.004*** 
(0.001) 
-0.003*** 
(0.001) 
-0.003*** 
(0.001) 
𝐻𝐻𝐼𝑖,𝑡 
-0.042*** 
(0.004) 
-0.042*** 
(0.004) 
-0.036*** 
(0.004) 
-0.036*** 
(0.004) 
-0.032*** 
(0.004) 
-0.032*** 
(0.004) 
Constant 
0.408*** 
(0.021) 
0.397*** 
(0.022) 
0.414*** 
(0.021) 
0.410*** 
(0.021) 
0.391*** 
(0.020) 
0.389*** 
(0.020) 
Fixed-effects Yes Yes Yes Yes Yes Yes 
R2 0.244 0.245 0.275 0.276 0.307 0.307 
Observations 9,541 9,541 9,541 9,541 9,541 9,541 
Number of hospitals 1,965 1,965 1,965 1,965 1,965 1,965 
Note: Robust standard errors are in parentheses; ***p<0.01, **p<0.05, *p<0.1.  
Table 3. Estimation results for HRRs with an HHI below 0.15 (Panel A) 
Variables (1) (2) (3) (4) (5) (6) 
𝐸𝐷𝐼𝑖,𝑡−1 
-0.007*** 
(0.002) 
0.009 
(0.011) 
  
0.004 
(0.012) 
-0.009 
(0.014) 
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 
-0.093*** 
(0.004) 
-0.076*** 
(0.013)   
-0.017 
(0.014) 
-0.030* 
(0.016) 
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1 
 -0.019 
(0.013)   
-0.012 
(0.014) 
0.022 
(0.020) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1 
  -0.005** 
(0.002) 
0.006 
(0.006) 
0.008 
(0.006) 
0.004 
(0.007) 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 
  -0.099*** 
(0.005) 
-0.086*** 
(0.008) 
-0.062*** 
(0.010) 
-0.050*** 
(0.011) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 
  
 
-0.018** 
(0.009) 
-0.025** 
(0.010) 
-0.014 
(0.010) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1     
0.005 
(0.006) 
 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1      
-0.025** 
(0.012) 
Constants 
0.365*** 
(0.035) 
0.350*** 
(0.038) 
0.341*** 
(0.033) 
0.334*** 
(0.033) 
0.327*** 
(0.035) 
0.332*** 
(0.036) 
Controls Yes Yes Yes Yes Yes Yes 
Fixed-effects Yes Yes Yes Yes Yes Yes 
R2 0.303 0.304 0.357 0.358 0.364 0.365 
Observations 4,168 4,168 4,168 4,168 4,168 4,168 
Number of hospitals 855 855 855 855 855 855 
Note: Robust standard errors are in parentheses. *** p<0.01, ** p<0.05, * p<0.1. The results of the control variables are not shown 
for expositional brevity. 
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Table 4. Estimation results for HRRs with an HHI between 0.15 and 0.25 (Panel B) 
Variables (1) (2) (3) (4) (5) (6) 
𝐸𝐷𝐼𝑖,𝑡−1 
-0.004* 
(0.002) 
0.016 
(0.010) 
  
0.015 
(0.011) 
0.019 
(0.012) 
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 
-0.061*** 
(0.004) 
-0.040*** 
(0.011) 
  
-0.017 
(0.012) 
-0.015 
(0.013) 
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1  
-0.024** 
(0.011) 
  
-0.015 
(0.013) 
-0.030* 
(0.017) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1   
-0.005* 
(0.003) 
-0.006 
(0.008) 
0.003 
(0.009) 
-0.003 
(0.008) 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1   
-0.066*** 
(0.005) 
-0.068*** 
(0.010) 
-0.051*** 
(0.011) 
-0.052*** 
(0.013) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1    
0.002 
(0.012) 
0.005 
(0.013) 
-0.002 
(0.013) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1     
-0.013** 
(0.006) 
 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1      
0.007 
(0.011) 
Constants 
0.427*** 
(0.046) 
0.411*** 
(0.047) 
0.403*** 
(0.045) 
0.403*** 
(0.045) 
0.379*** 
(0.044) 
0.381*** 
(0.044) 
Controls Yes Yes Yes Yes Yes Yes 
Fixed-effects Yes Yes Yes Yes Yes Yes 
R2 0.221 0.223 0.250 0.250 0.291 0.289 
Observations 2,481 2,481 2,481 2,481 2,481 2,481 
Number of hospitals 507 507 507 507 507 507 
Note: Robust standard errors are in parentheses. ***p<0.01, **p<0.05, *p<0.1. The results of the control variables are 
not shown for expositional brevity. 
 
Table 5. Estimation results for HRRs with an HHI above 0.25 (Panel C) 
Variables (1) (2) (3) (4) (5) (6) 
𝐸𝐷𝐼𝑖,𝑡−1 
-0.005** 
(0.002) 
-0.000 
(0.006) 
  
-0.004 
(0.006) 
-0.004 
(0.006) 
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 
-0.040*** 
(0.002) 
-0.035*** 
(0.007) 
  
-0.025*** 
(0.007) 
-0.029*** 
(0.007) 
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1  
-0.005 
(0.008) 
  
0.007 
(0.008) 
0.007 
(0.009) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1   
-0.004* 
(0.002) 
-0.000 
(0.004) 
0.007 
(0.005) 
-0.001 
(0.004) 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1   
-0.044*** 
(0.003) 
-0.040*** 
(0.005) 
-0.030*** 
(0.006) 
-0.020*** 
(0.007) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1    
-0.006 
(0.007) 
0.001 
(0.007) 
-0.003 
(0.006) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1     
-0.013*** 
(0.005) 
 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1  × 𝐸𝐷𝐼𝑖,𝑡−1  × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1      
-0.010 
(0.006) 
Constants 
0.413*** 
(0.031) 
0.410*** 
(0.031) 
0.446*** 
(0.030) 
0.445*** 
(0.030) 
0.425*** 
(0.029) 
0.420*** 
(0.029) 
Controls Yes Yes Yes Yes Yes Yes 
Fixed-effects Yes Yes Yes Yes Yes Yes 
R2 0.245 0.245 0.255 0.255 0.301 0.299 
Observations 2,892 2,892 2,892 2,892 2,892 2,892 
Number of hospitals 603 603 603 603 603 603 
Note: Robust standard errors are in parentheses. ***p<0.01, **p<0.05, *p<0.1. The results of the control variables are 
not shown for expositional brevity. 
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The coefficients for 𝐻𝐼𝑇𝑖,𝑡−1  are negative and 
significant in all subsamples. The coefficients for 
𝐻𝐼𝑇𝑟−𝑖,𝑡−1 are also negative and significant for both EDI 
and CDSS in all subsamples (-0.093, -0.061, and -0.040 
for EDI and -0.099, -0.066, and -0.044 for CDSS, for 
Panels A, B, and C, respectively). To compare the 
spillover effects across subsamples, we further estimate 
our models with the standardized variables. The 
standardized coefficients of 𝐻𝐼𝑇𝑟−𝑖,𝑡−1 for Panels A, B, 
and C are -0.605, -0.400, and -0.264 for EDI and -0.808, 
-0.541, and -0.368 for CDSS, respectively. These results 
consistently indicate the spillover effects of HIT 
adoption are negatively proportional to HRRs’ HHIs. 
We test the equality of the coefficients across panels and 
find that the difference between the standardized 
coefficients from Panel A and Panel B, and Panel B and 
Panel C is statistically significant for both EDI and 
CDSS (the t-values are -5.048 and -3.297 for EDI, and -
4.785 and -3.847 for CDSS, respectively). The results 
imply that spillover effects are greatest for HRRs with a 
low-concentrated market, followed by HRRs with a 
moderately and a highly concentrated market. Further, 
the coefficient estimate of the interaction term is found 
significant only for CDSS and in low-concentrated 
markets (-0.018 at p-value < 0.01 in Model (4) at Table 
3). 
The results illustrate that spillover effects depend on 
HRRs’ market structures. Specifically, the effects are 
prevalent when the healthcare market is very 
competitive, such that there are many hospital choices 
for referrals or collaborations. These effects, however, 
diminish when a few hospitals are dominating in the 
referral region. 
 
 
4.2. The role of EDI in generating the spillover 
effects of CDSS 
  
EDI systems have been adopted to support effective 
communication among hospitals. EDI allows hospitals 
to exchange electronic clinical documentation such as 
patient demographics, physician notes, nursing notes, 
medication lists, and problem lists in a fast and errorless 
manner. The diagnosis and treatment history, and 
medication records supported by CDSS at the initial 
hospital can be safely transmitted to the referred hospital 
through the system. 
To estimate the technology dependency of CDSS on 
EDI in generating spillover effects, we incorporate a 
three-way interaction term into our main models (Eq. 3 
and Eq. 4): 
 
 
 
𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1𝐸𝐷𝐼𝑖,𝑡−1 + 𝛽2𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽3𝐸𝐷𝐼𝑖,𝑡−1 × 
                𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽4𝐶𝐷𝑆𝑆𝑖,𝑡−1 + 𝛽5𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 + 
                𝛽6𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 + 𝛽7𝐸𝐷𝐼𝑖,𝑡−1 × 
                𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡  + 𝜇𝑖 + 𝜀𝑖,𝑡          
(Eq.3) 
𝑟ℎ𝑓𝑖,𝑡 = 𝛽0 + 𝛽1𝐸𝐷𝐼𝑖,𝑡−1 + 𝛽2𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽3𝐸𝐷𝐼𝑖,𝑡−1 ×
  𝐸𝐷𝐼𝑟−𝑖,𝑡−1 + 𝛽4𝐶𝐷𝑆𝑆𝑖,𝑡−1 + 𝛽5𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 +
  𝛽6𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 + 𝛽7𝐸𝐷𝐼𝑖,𝑡−1 ×
  𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 + 𝛾𝑋𝑖,𝑡  + 𝜇𝑖 + 𝜀𝑖,𝑡   
            (Eq. 4) 
Models (5) and (6) of Table 1 contain the analysis 
results. The negative and significant coefficient of  
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑖,𝑡−1  demonstrates that 
the main effects of CDSS adoption are greater when 
both a focal hospital and its neighbors have 
implemented EDI. The negative and significant 
coefficient of 𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1 
demonstrates that the spillover effect of CDSS adoption 
is significant among hospitals in an HRR. These 
findings further imply that the effects of hospitals’ 
CDSS and EDI adoptions are interdependent for 
delivering high-quality healthcare service. 
 
4.3. Network externality: HRR-level analysis 
 
Considering possible spillover effects, the overall 
HIT adoption at the HRR level could contribute to the 
healthcare quality of the region. We conduct an HRR-
level analysis to examine how an HRR’s average 
adoption rates of EDI and CDSS affect its average 
readmission rate. The model specifications are the same 
as our main models, except that all of the variables are 
HRR-level. 
Table 6. HRR-level estimation results 
Variables (1) (2) (3) (4) 
𝐸𝐷𝐼𝑟,𝑡−1 
-0.034*** 
(0.005) 
 
-0.026*** 
(0.004) 
-0.017 
(0.013) 
𝐶𝐷𝑆𝑆𝑟,𝑡−1  
-0.032*** 
(0.004) 
-0.027*** 
(0.004) 
-0.012 
(0.019) 
𝐸𝐷𝐼𝑟,𝑡−1
× 𝐶𝐷𝑆𝑆𝑟,𝑡−1 
   
-0.016 
(0.020) 
Constants 
0.748*** 
(0.070) 
0.767*** 
(0.067) 
0.734*** 
(0.066) 
0.724*** 
(0.066) 
Controls Yes Yes Yes Yes 
Fixed-effects Yes Yes Yes Yes 
R2 0.449 0.463 0.487 0.487 
Observations 1,150 1,150 1,150 1,150 
Number of 
HRRs 
232 232 232 232 
Note: EDIr,t-1 (CDSSr,t-1) is the average adoption rate of EDI 
(CDSS) of the HRR r at t-1. The dependent variable is the 
average readmission rate of heart failure in the HRR. The 
results of the control variables are not shown for expositional 
brevity. 
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Table 6 contains the results. The average adoption 
rates of EDI (-0.026 at p-value < 0.01) and CDSS (-
0.027 at p-value < 0.01) in an HRR are associated with 
a decrease in the average readmission rate of the HRR, 
which illustrates the negative effects. However, their 
interaction does not have any effect at the HRR level. 
 
4.4. Meaningful use 
 
In terms of HIT adoption, an assimilation gap 
between simple HIT implementation and actual usage 
could exist in a hospital [12], and gap ranges are 
possibly diverse across hospitals. Such gaps normally 
result from a lack of knowledge in leveraging various 
types of HIT and misalignment between HIT and 
internal clinical workflows. Thus, we further integrate a 
hospital’s actual usage, which is measured as a 
hospital’s meaningful-use attestation, into our models. 
This analysis can identify how the effect of HIT 
adoption varies with a hospital’s actual usage. Actual 
usage was measured by whether a hospital attested to 
the meaningful-use Stage 2, which was initiated in 2014 
and expanded the meaningful-use Stage 1 criteria (i.e., 
improving data capture and sharing) to advanced care 
processes with decision support. The purposes of the 
meaningful-use Stage 2 beyond Stage 1 are well aligned 
with the adoption of CDSS and EDI. While Stage 1 does 
not pay much attention to data exchange and the use of 
CDSS, Stage 2 requires all medical documents to be sent 
electronically to other hospitals for at least 50 percent of 
referral cases and concerns the meaningful use of CDSS 
functionalities. 
Thus, we further test whether meaningful use, which 
is measured by the receipt of the Stage 2 certificate, 
makes any difference on the spillover effects of HIT 
adoption. We apply our panel models, Eq. 1 and Eq. 2, 
to hospitals that are certified as Stage 2 and hospitals 
that are not certified, separately. There are 1,525 
hospitals in Stage 2 and 440 hospitals in Stage 1 or 
below in 2015. 
Table 7 shows the estimation results. With respect to 
Stage 2 hospitals, the estimates for 𝐻𝐼𝑇𝑖,𝑡−1  and 
𝐻𝐼𝑇𝑟−𝑖,𝑡−1  are negative and significant in Models (1) 
and (3), and the estimates for their interaction terms are 
also negative and significant for both EDI and CDSS in 
Models (2) and (4). 
However, in Stage 1 hospitals, the effects of HIT 
adoption (especially, CDSS) become insignificant in 
Model (6) ~ (8), suggesting that hospitals having 
relatively low-level actual usage cannot fully utilize 
adopted CDSS for a better quality of care. Further, the 
interaction terms of 𝐻𝐼𝑇𝑖,𝑡−1  and 𝐻𝐼𝑇𝑟−𝑖,𝑡−1  have 
insignificant coefficients for both EDI and CDSS 
(Models (6) and (8)), implying that meaningful HIT 
usage drives the spillover effects in an HRR. 
 
5. Conclusion 
 
This study investigates the effects of CDSS and EDI 
on the hospital readmission rates for heart failure 
patients. Using the large-scale hospital panel datasets 
from multiple sources, we find evidence that a hospital’s 
HIT adoption is associated with a subsequent reduction 
in its readmission rate. We also reveal the spillover 
effects of HIT adoption within an HRR. These spillover 
effects become stronger for an HRR with less 
concentrated healthcare markets – competitive 
healthcare markets. Furthermore, our results indicate 
that a focal hospital’s EDI adoption along with its 
neighboring hospitals is critical in fostering the spillover 
effects of CDSS adoption in the HRR. 
Our results highlight the importance of government-
driven HIT investments in the U.S. The spillover effects 
become greater for hospitals that have adopted HIT, 
along with a higher HIT adoption level within the HRR. 
The negative impact of HIT adoption on a hospital’s 
readmission rate can be greater with the adoption of the 
other hospitals in the HRR. 
Such spillover effects vary with the market 
concentrations of regional healthcare markets. The 
spillover effects of both EDI and CDSS are strongest for 
HRRs with an unconcentrated healthcare market, 
followed by HRRs with a moderately concentrated 
healthcare market. The spillover effects are weakest for 
HRRs with a highly concentrated healthcare market. 
This finding suggests that policies for effective HIT 
adoption should consider various regional market 
structures. Therefore, government interventions aiming 
at maximizing the spillover effects of HIT adoption 
need to be tailored, based on types of healthcare market 
structures. 
The spillover effect of CDSS adoption becomes 
greater when a focal hospital adopts EDI and the 
average EDI adoption rate of neighboring hospitals in 
its HRR is higher. EDI adoption moderates the spillover 
effects of CDSS adoption. This indicates the technology 
interdependence among HITs in enhancing healthcare 
quality.
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Table 7. Estimation results of hospitals by meaningful use 
 Hospitals in Stage 2 Hospitals in Stage 1 or Below 
Variables (1) (2) (3) (4) (5) (6) (7) (8) 
𝐸𝐷𝐼𝑖,𝑡−1 
-0.007*** 
(0.002) 
0.006 
(0.006) 
  -0.004* 
(0.002) 
0.010 
(0.010) 
  
𝐸𝐷𝐼𝑟−𝑖,𝑡−1 
-0.058*** 
(0.003) 
-0.043*** 
(0.006) 
  -0.059*** 
(0.004) 
-0.044*** 
(0.012) 
  
𝐸𝐷𝐼𝑖,𝑡−1 × 𝐸𝐷𝐼𝑟−𝑖,𝑡−1  
-0.016** 
(0.007) 
  
 
-0.016 
(0.012) 
  
𝐶𝐷𝑆𝑆𝑖,𝑡−1   
-0.006*** 
(0.002) 
0.006 
(0.004) 
  
-0.004 
(0.003) 
-0.010 
(0.007) 
𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1   
-0.066*** 
(0.003) 
-0.053*** 
(0.005) 
  
-0.060*** 
(0.007) 
-0.066*** 
(0.008) 
𝐶𝐷𝑆𝑆𝑖,𝑡−1 × 𝐶𝐷𝑆𝑆𝑟−𝑖,𝑡−1    
-0.019*** 
(0.006) 
   
0.011 
(0.011) 
Constants 
0.429*** 
(0.025) 
0.418*** 
(0.025) 
0.431*** 
(0.023) 
0.426*** 
(0.023) 
0.331*** 
(0.042) 
0.317*** 
(0.042) 
0.346*** 
(0.042) 
0.348*** 
(0.042) 
Controls Yes Yes Yes Yes Yes Yes Yes Yes 
Fixed-effects Yes Yes Yes Yes Yes Yes Yes Yes 
R2 0.235 0.236 0.274 0.276 0.290 0.291 0.283 0.284 
Observations 7,464 7,464 7,464 7,464 2,077 2,077 2,077 2,077 
Number of hospitals 1,525 1,525 1,525 1,525 440 440 440 440 
Note: Robust standard errors are in parentheses. ***p<0.01, **p<0.05, *p<0.1. The results of the control variables are 
not shown for expositional brevity 
 
Our study contributes to the growing body of 
literature on the impacts of HITs. While most prior 
empirical studies focus on the hospital or physician-
level effects of HIT adoption based on a small sample, 
we use nationwide large panels to examine not only the 
hospital-level effects of the adoption but also possible 
spillover effects at an HRR level. A few recent studies 
have paid attention to the spillover effects of HIT 
adoptions; however, their focus is on the cost side [3, 5]. 
To the best of our knowledge, this study is one of the 
first studies to provide empirical evidence of the 
spillover effects of HIT adoption on healthcare quality 
considering market concentrations and actual usage 
beyond simple HIT implementation. The subsample 
analysis across various market concentrations provides 
the market conditions where spillover effects can prevail. 
The analysis on the three-way interaction of EDI 
adoption, the EDI adoption rate in the HRR, and CDSS 
adoption highlights the importance of infrastructure for 
effective communication among hospitals in terms of 
fostering the spillover effects of standalone technology. 
We further found that the spillover effects of HIT 
adoption increase along with higher actual HIT usage. 
While we focus on the effects of two types of 
HITs—CDSS and EDI, the effects of other HITs can be 
explored as well in the next step. If an analysis of other 
technologies shows different results, such that no 
spillover effect is found, it would be interesting to 
investigate which technological characteristics of HITs 
drive such differential results. We can also replicate the 
analysis for other major causes of hospital readmission, 
such as pneumonia or acute myocardial infarction, in 
our future research. 
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